Search research articles
Contact Us
Filters
Showing results (11-20 of 133) with videos related to
Page
of 14
Sort By:
Lancet (London, England)
|
March 1, 2011
Efficacy and safety of more intensive lowering of LDL cholesterol
Philippe Giral, Philippe Moulin, David Rosenbaum
Circulation
|
June 2, 2016
Letter by Hoang et al Regarding Article, "Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease"
Sophie Hoang, Xavier Girerd, Philippe Giral
JAMA Cardiology
|
February 2, 2022
Hypertriglyceridemia in the MESA Study
Boris Hansel, Ronan Roussel, Philippe Giral
Lancet (London, England)
|
May 5, 2018
Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple?
Boris Hansel, Ronan Roussel, Philippe Giral
Journal of the American College of Cardiology
|
January 22, 2016
Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS
Philippe Giral, Boris Hansel, John Chapman
Circulation
|
March 1, 2006
Letter regarding article by Ruttmann et al, "gamma-Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults"
Philippe Giral, Vlad Ratziu, John C Chapman
JAMA Cardiology
|
March 18, 2026
Advancing Retinal Imaging for Cardiovascular Risk Assessment
Federico Bernardo Rossi, Antonio Gallo, Philippe Giral
Clinical Chemistry
|
September 2, 2020
LDL Cholesterol: 'The Times They Are A-Changin'
M John Chapman, Philippe Giral, Patrice Therond
Circulation
|
October 22, 2014
Letter by Giral et al regarding article, "lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)"
Philippe Giral, Dominique Simon, M John Chapman
Current Opinion in Clinical Nutrition and Metabolic Care
|
September 9, 2010
Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?
Jean-Louis Beaudeux, Valérie Nivet-Antoine, Philippe Giral
Page
of 14
Search research articles
Search
Showing results (11-20 of 133) with videos related to
Sort By:
Page
of 14
Lancet (London, England)
|
March 1, 2011
Efficacy and safety of more intensive lowering of LDL cholesterol
Philippe Giral, Philippe Moulin, David Rosenbaum
Circulation
|
June 2, 2016
Letter by Hoang et al Regarding Article, "Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease"
Sophie Hoang, Xavier Girerd, Philippe Giral
JAMA Cardiology
|
February 2, 2022
Hypertriglyceridemia in the MESA Study
Boris Hansel, Ronan Roussel, Philippe Giral
Lancet (London, England)
|
May 5, 2018
Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple?
Boris Hansel, Ronan Roussel, Philippe Giral
Journal of the American College of Cardiology
|
January 22, 2016
Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS
Philippe Giral, Boris Hansel, John Chapman
Circulation
|
March 1, 2006
Letter regarding article by Ruttmann et al, "gamma-Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults"
Philippe Giral, Vlad Ratziu, John C Chapman
JAMA Cardiology
|
March 18, 2026
Advancing Retinal Imaging for Cardiovascular Risk Assessment
Federico Bernardo Rossi, Antonio Gallo, Philippe Giral
Clinical Chemistry
|
September 2, 2020
LDL Cholesterol: 'The Times They Are A-Changin'
M John Chapman, Philippe Giral, Patrice Therond
Circulation
|
October 22, 2014
Letter by Giral et al regarding article, "lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)"
Philippe Giral, Dominique Simon, M John Chapman
Current Opinion in Clinical Nutrition and Metabolic Care
|
September 9, 2010
Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?
Jean-Louis Beaudeux, Valérie Nivet-Antoine, Philippe Giral
Page
of 14